Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70431 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, 2026. Written by Christy Riggott and 6 co-authors. Institution: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK. Major MEDLINE topics: Anxiety, Depression, Inflammatory Bowel Diseases. Cited 4 times so far (Crossref); 57 references.
Topics: Depression
Abstract (original language)
Background
Poor psychological health affects many patients with inflammatory bowel disease (IBD), but the persistence of these symptoms is unclear.
Methods
We performed a longitudinal follow‐up study of patients whose anxiety and depression trajectories were established by symptom data collected at 3‐monthly intervals over the course of 1 year. We collected further anxiety and depression symptom data at yearly intervals over 2 years to determine the persistence of these symptoms in patients with IBD. Disease outcomes (flare/need for glucocorticosteroids, escalation of medical therapy, hospitalisation, or intestinal resection) were recorded to determine the effect of mood trajectories on the natural history of IBD.
Results
Of 770 patients with established anxiety trajectories, 486 (63.1%) provided further anxiety symptom data at 12 months, and 358 (45.5%) at 24 months. Of the 777 patients with established depression trajectories, 491 (63.2%) provided further depression symptom data at 12 months, and 362 (45.6%) at 24 months. Participants with symptoms of anxiety at 24 months were more likely to have a fluctuating, or persistently abnormal or worsening, anxiety trajectory during the first year ( p < 0.001 for trend). Participants with symptoms of depression at 24 months were more likely to have a fluctuating, or persistently abnormal or worsening, depression trajectory during the first year ( p < 0.001 for trend). Adverse disease outcomes were no more likely according to anxiety or depression trajectories.
Discussion
Poor psychological health persists for a substantial number of patients with IBD. Further work is needed to establish the long‐term effect of mood trajectories on disease outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
- Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
- Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
ORCID profiles: Christy Riggott, Keeley M Fairbrass, Christopher J Black, Alexander C Ford
Cite
APA
Riggott, C., Fairbrass, K. M., Guthrie, E. A., Black, C. J., Selinger, C. P., Ford, A. C., & Gracie, D. J. (2026). Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70431
Vancouver
Riggott C, Fairbrass KM, Guthrie EA, Black CJ, Selinger CP, Ford AC, et al. Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70431
BibTeX
@article{Riggott2026,
author = {Riggott, Christy and Fairbrass, Keeley M and Guthrie, Elspeth A and Black, Christopher J and Selinger, Christian P and Ford, Alexander C and Gracie, David J},
title = {Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70431}
}
EUVIMED